Case Review Form

      * Denotes required field.


      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address




      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Pennsylvania Man Claims Taking Actos Led To Bladder Cancer

Filed June 10th, 2013 Joshua Sophy

A Pennsylvania man is the latest to claim that taking the type 2 diabetes drug Actos caused him to develop life-threatening bladder cancer.

He has filed a lawsuit that’s being consolidated with other similar cases across the U.S. in which patients taking Actos developed bladder cancer. The diabetics included in the federal multidistrict litigation (MDL) say that the maker of Actos, Japan-based Takeda Pharmaceuticals, failed to warn of this potentially deadly risk associated with its popular drug treatment.

The Pennsylvania man is being represented by the national law firm of Parker Waichman LLP. The firm has taken a leading role in representing people who’ve developed bladder cancer after starting to take Actos to treat their type 2 diabetes. The firm’s founding partner, Jerrold S. Parker, was recently named to the Plaintiffs’ Steering Committee in the MDL that’s been consolidated in U.S. District Court for the Western District of Louisiana.

In this latest case, the Pennsylvania man says he started taking Actos in November 2003. Less than three years later, in August 2006, he was diagnosed with bladder cancer. His lawsuit, like others before him, claims that Actos knew about but failed to warn the public of the risk of bladder cancer associated with the drug, according to a release announcing the lawsuit.

Two years ago, the U.S. Food and Drug Administration confirmed growing complaints that Actos was responsible for causing bladder cancer, according to our previous reports. At that time, the FDA said that taking Actos for longer than a year or at high doses could significantly increase a diabetic’s risk of developing bladder cancer.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!